Caricamento...
Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy
With the use of nucleoside analogs as frontline therapy, the prognosis of hairy cell leukemia (HCL) has improved dramatically. Unfortunately, disease recurrence remains problematic. Eradication of minimal residual disease (MRD) persisting after therapy may further improve outcome. The evolution of a...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4109291/ https://ncbi.nlm.nih.gov/pubmed/19814695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428190903142224 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|